This study demonstrates that Ophiopogonin D exerts anti-HCC effects through the UCK2-SLC7A11 axis, providing experimental evidence and molecular mechanisms to support the development of novel anti-HCC drugs derived from medicinal foods. This evidence concerns the gene UCK2 and hepatocellular carcinoma.